Jaanch - Tumour Panel Test - Female

Tumour Panel (Female) blood tests can provide valuable information in the context of female-specific cancers such as:

• CA-125: CA-125 is a tumor marker that can be measured in the blood. It is primarily used in the diagnosis and monitoring of ovarian cancer. Elevated CA-125 levels may indicate the presence of ovarian cancer, although further diagnostic procedures, such as imaging or biopsies, are typically required for a definitive diagnosis.
• CA 15-3: CA 15-3 is a tumor marker primarily associated with breast cancer. It measures the level of a protein called carbohydrate antigen 15-3 in the blood. Elevated levels of CA 15-3 may indicate the presence of breast cancer, particularly in individuals with advanced or metastatic disease. CA 15-3 levels can be useful in monitoring response to treatment and tracking disease progression in breast cancer patients.
• CA 19-9: CA 19-9 is a tumor marker used mainly in the evaluation of pancreatic and gastrointestinal cancers, including pancreatic, colorectal, and gastric cancers. It measures the level of a specific carbohydrate antigen in the blood. Elevated CA 19-9 levels can be indicative of these types of cancers, but they can also be elevated in certain non-cancerous conditions. CA 19-9 is often used to monitor treatment response and disease recurrence in pancreatic cancer patients.
• Carcinoembryonic Antigen (CEA): CEA is a tumor marker that is associated with several types of cancers, most notably colorectal cancer. It is also used in the diagnosis and monitoring of other gastrointestinal cancers, such as pancreatic, liver, and lung cancers. Elevated CEA levels can indicate the presence of these cancers, but they can also be elevated in non-cancerous conditions, such as inflammatory bowel disease or smoking. CEA levels are monitored during and after treatment to assess response and detect cancer recurrence.
• Alpha-Fetoprotein (AFP): AFP is a protein produced by the developing fetus, and elevated levels of AFP in the blood can indicate certain medical conditions, including liver diseases and certain cancers. In the context of cancer, AFP is primarily used in the diagnosis and monitoring of hepatocellular carcinoma (HCC), a type of liver cancer, and non-seminomatous germ cell tumors, such as testicular cancer.